DAKMELA Trademark

Trademark Overview

On Saturday, October 14, 2017, a trademark application was filed for DAKMELA with the United States Patent and Trademark Office. The USPTO has given the DAKMELA trademark a serial number of 87645798. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 22, 2021. This trademark is owned by Bristol-Myers Squibb Company. The DAKMELA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies
dakmela

General Information

Serial Number87645798
Word MarkDAKMELA
Filing DateSaturday, October 14, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 22, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 21, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use for the treatment and prevention of obesity, diabetes, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants and pharmaceutical antibodies

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, October 24, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBristol-Myers Squibb Company
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 08543
Party NameBristol-Myers Squibb Company
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10154

Trademark Events

Event DateEvent Description
Wednesday, August 2, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 2, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 2, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 22, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 22, 2021ABANDONMENT - NO USE STATEMENT FILED
Friday, April 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 1, 2021SOU EXTENSION 5 GRANTED
Tuesday, March 30, 2021SOU EXTENSION 5 FILED
Tuesday, March 30, 2021TEAS EXTENSION RECEIVED
Thursday, February 11, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 4 GRANTED
Friday, October 16, 2020SOU EXTENSION 4 FILED
Tuesday, February 9, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 11, 2020NOTICE OF REVIVAL - E-MAILED
Tuesday, November 10, 2020EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, November 10, 2020PETITION TO REVIVE-GRANTED
Tuesday, November 10, 2020TEAS PETITION TO REVIVE RECEIVED
Saturday, April 18, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 16, 2020SOU EXTENSION 3 GRANTED
Thursday, April 16, 2020SOU EXTENSION 3 FILED
Thursday, April 16, 2020TEAS EXTENSION RECEIVED
Friday, October 18, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 16, 2019SOU EXTENSION 2 GRANTED
Wednesday, October 16, 2019SOU EXTENSION 2 FILED
Wednesday, October 16, 2019TEAS EXTENSION RECEIVED
Saturday, March 30, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 28, 2019SOU EXTENSION 1 GRANTED
Thursday, March 28, 2019SOU EXTENSION 1 FILED
Thursday, March 28, 2019TEAS EXTENSION RECEIVED
Tuesday, October 16, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, October 8, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 8, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 21, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 21, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 21, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 1, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 13, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 12, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 12, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 12, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 12, 2018NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 12, 2018NON-FINAL ACTION E-MAILED
Friday, January 12, 2018NON-FINAL ACTION WRITTEN
Monday, January 8, 2018ASSIGNED TO EXAMINER
Tuesday, October 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 18, 2017NEW APPLICATION ENTERED

Related Keywords

dakmela diseases pharmaceutical human anti preparations disorders organ solid auto immune